GeekWire Logo
Menu
  • Home
  • News
    • Amazon
    • Artificial Intelligence
    • Civic
    • Geek Life
    • Health/Life Sciences
    • Microsoft
    • GeekWire Podcast
    • Space
    • Startups sponsored by Google for Startups
    • Positive Charge Podcast sponsored by Amazon Sustainability
    • Sustainability sponsored by Amazon Sustainability
    • Tech Moves presented by GeekWork Recruiting
    • Agents of Transformation presented by Accenture
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • GeekWire 200
    • GeekWire Startup List presented by ALLtech
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • F5 30th Anniversary
    • AI Breakthrough Awards presented by UiPath
    • AI Innovators Spotlight Studio 2026 presented by AWS Marketplace
    • Nebius at NVIDIA GTC 2026
    • Acumatica Summit 2026
    • BMC Control Freaks Unite presented by BMC
    • AI Predictions Series 2026 presented by Unify Consulting
    • Guide to re:Invent 2025 sponsored by AWS
    • Remitly Reimagine 2025 sponsored by Remitly
    • Does Compute presented by Carnegie Mellon University
    • AWS Marketplace Seller Conference 2025 sponsored by AWS
    • ShopTalk 2025 powered by Amazon Ads
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Disease

Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find

The question of why immunotherapy eradicates cancer in some people while having little effect on the majority of patients has… Read More

Paul Allen’s foundation opens challenge to combat Ebola outbreak in Congo

The Paul G. Allen Family Foundation is looking for smart ideas to fight Ebola and has opened a call for… Read More

Seattle biotech scores $67.5M to treat migraines and Parkinson’s with drugs delivered deep into the nasal cavity

Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central… Read More

Podcast

An ‘awesome year’? Gates Foundation CEO Sue Desmond-Hellmann has a radical view on 2017

It would be easy for Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, to look back on 2017… Read More

News Brief

Bill Gates to increase Malaria funding by 30 percent

Microsoft co-founder Bill Gates said Sunday that he plans to boost his foundation’s funding for malaria research and eradication by… Read More

Latest Stories

    Read All Stories

    GeekWire Newsletters

    Subscribe to GeekWire's free newsletters to catch every headline

    Send Us a Tip

    Have a scoop that you'd like GeekWire to cover? Let us know.

    Send Us a Tip

    A Word From Our Sponsors

    About

    • About GeekWire
    • Contact Us
    • Partner With Us
    • Become a GeekWire Member
    • Send Us a Tip
    • Join Our Startup List
    • Reprints and Permissions

    Follow

    • Facebook
    • X
    • LinkedIn
    • Instagram
    • RSS Feed
    • Podcast
    • YouTube
    • Bluesky

    GeekWire Newsletters

    Catch every headline in your inbox

    Read GeekWire

    • Apple News
    • Google News

    Legal

    • Privacy Policy
    • Terms of Use
    • Sponsored Content Policy
    Return to Top of Page
    © 2011-2026 GeekWire, LLC
    Do Not Sell or Share My Personal information
    Limit the Use Of My Sensitive Personal Information
    Consent Preferences

    Don't miss a headline!

    Sign up for GeekWire's newsletters today.

    Thanks for subscribing!
    Check your inbox to confirm your subscription.